Media Inquiries
For general media inquiries, please contact media@hhs.gov.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Health and Human Services Secretary Xavier Becerra today issued a new report highlighting the progress that has been made over the past year to strengthen the U.S. public health and medical supply chain and industrial base.
The report highlights the U.S. government’s accomplishments in addressing public health and medical supply chain challenges since the beginning of the COVID-19 pandemic, describes how HHS is implementing the recommendations and goals in the National Strategy for a Resilient Public Health Supply Chain, and outlines additional actions the U.S. government can take to build on its progress.
“The COVID-19 pandemic has revealed just how vulnerable the U.S. supply chain and U.S. manufacturing were in years past. Our reliance on manufacturing overseas created significant medical supply shortages for health care workers and put the health and security of the American people in danger,” said Secretary Becerra. “The Biden-Harris Administration, working with private industry, has made great strides in addressing these inherited challenges, for example, quadrupling the monthly supply of at-home COVID-19 rapid tests in the United States to ensure students and workers arrive healthy to schools and their places of employment.”
Over the past year, HHS has invested $250 million in U.S.-based manufacturing of personal protective equipment (PPE) and $950 million in manufacturing the supplies and equipment needed for vaccines, therapeutics, and diagnostic tests. Through partnerships with the private sector, utilization of the Defense Product Act, and reallocation of resources, HHS has distributed more than 685 million vaccine doses to 90,000 vaccination sites nationwide, launched a program to deliver up to 500 million free COVID-19 tests to Americans’ homes, and shipped hundreds of millions of N95 masks to pharmacies and community health clinics nationwide so that any American who wants a higher-quality mask can get one.
“Today we have the tools we need to fight the pandemic—vaccines and boosters, tests, and treatments—thanks to the Biden-Harris’ Administration’s sustained focus on building U.S.-based capacity for critical medical supplies,” said HHS Assistant Secretary for Preparedness and Response Dawn O’Connell. “Over the past year, as a result of strong collaboration between public and private sectors, we’ve significantly increased U.S.-made PPE, tests and diagnostic devices, therapeutics, vaccines, and the active pharmaceutical ingredients to make them. For example, in January 2021, the U.S. had no over-the-counter antigen tests and today we have hundreds of millions of tests per month, with an anticipated capacity to produce over 1 billion a month beginning in March.
In 2021, HHS experts analyzed three critical supply chains: PPE and durable medical equipment; testing and diagnostics; and pharmaceuticals—including vaccines. Factors that contributed to the lack of security in medical supply chains included reliance on foreign sources for components of medical supplies, focus on lowest-cost, reducing diversity across the supply chain, workforce shortages, financial barriers to entry and expansion, and lack of visibility and coordination across the supply chain.
Specific progress in development, procurement, and distribution efforts described in the report includes:
The report is one of six reports on America’s supply chains in response to Executive Order 14017. HHS is the lead federal department for this effort and continues to coordinate the federal response to strengthen the public health and medical supply chain and expand the capacity of the nation’s domestic industrial base to build back better in the face of future health security threats.
To learn more about the industrial base expansion efforts and pharmaceutical manufacturing in America, visit aspr.hhs.gov.
Receive the latest updates from the Secretary, Blogs, and News Releases
For general media inquiries, please contact media@hhs.gov.
For more information on HHS's web notification policies, see Website Disclaimers.